Literature DB >> 22619342

The perilous state of independent randomized clinical trials and related applied research in Canada.

Salim Yusuf1, John Cairns.   

Abstract

Mesh：

Year:  2012        PMID： 22619342      PMCID： PMC3519168          DOI： 10.1503/cmaj.110598

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  25 in total

1.  Randomized clinical trials: slow death by a thousand unnecessary policies?

Authors:  Salim Yusuf
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  The Burlington randomized trial of the nurse practitioner.

Authors:  W O Spitzer; D L Sackett; J C Sibley; R S Roberts; M Gent; D J Kergin; B C Hackett; A Olynich
Journal:  N Engl J Med       Date:  1974-01-31       Impact factor: 91.245

4.  Aspirin, heparin, or both to treat acute unstable angina.

Authors:  P Théroux; H Ouimet; J McCans; J G Latour; P Joly; G Lévy; E Pelletier; M Juneau; J Stasiak; P deGuise
Journal:  N Engl J Med       Date:  1988-10-27       Impact factor: 91.245

5.  Translation of highly promising basic science research into clinical applications.

Authors:  Despina G Contopoulos-Ioannidis; Evangelia Ntzani; John P A Ioannidis
Journal:  Am J Med       Date:  2003-04-15       Impact factor: 4.965

6.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

7.  Increased absenteeism from work after detection and labeling of hypertensive patients.

Authors:  R B Haynes; D L Sackett; D W Taylor; E S Gibson; A L Johnson
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

8.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

Authors:  J A Cairns; M Gent; J Singer; K J Finnie; G M Froggatt; D A Holder; G Jablonsky; W J Kostuk; L J Melendez; M G Myers
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

10.  Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).

Authors:  Janusz Kaczorowski; Larry W Chambers; Lisa Dolovich; J Michael Paterson; Tina Karwalajtys; Tracy Gierman; Barbara Farrell; Beatrice McDonough; Lehana Thabane; Karen Tu; Brandon Zagorski; Ron Goeree; Cheryl A Levitt; William Hogg; Stephanie Laryea; Megan Ann Carter; Dana Cross; Rolf J Sabaldt
Journal:  BMJ       Date:  2011-02-07
View more
  2 in total

1.  Linkage of clinical trial and administrative data: a survey of cancer patient preferences.

Authors:  A E Hay; Y W Leung; J L Pater; M C Brown; E Bell; D Howell; Z Kassam; S Willing; C Tian; G Liu
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

Review 2.  Advancing Academic Cancer Clinical Trials Recruitment in Canada.

Authors:  Rebecca Y Xu; Diana Kato; Gregory R Pond; Stephen Sundquist; James Schoales; Saher Lalani; Janet E Dancey
Journal:  Curr Oncol       Date:  2021-07-28       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.